TORward AKTually useful mouse models (Q44915709)

7 December 2017

title

TORward AKTually useful mouse models (English)

1 reference

7 December 2017

Ingo K Mellinghoff

1 reference

7 December 2017

Charles L Sawyers

series ordinal

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

7 December 2017

1 reference

7 December 2017

1 reference

7 December 2017

1 reference

7 December 2017

page(s)

579-580

1 reference

Cancer modeling in the modern era: progress and challenges

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNM0604-579

mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0604-579

Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0604-579

An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0604-579

Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0604-579

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0604-579

Targeting epidermal growth factor receptor--are we missing the mark?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0604-579

Rheb fills a GAP between TSC and TOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0604-579

21 January 2018

Identifiers

DOI

10.1038/NM0604-579

1 reference

Dimensions Publication ID

7 December 2017

1041634277

0 references

1 reference